# Iron, B12 & Malabsorption originals (2026-05-10)
Preservation archive created before consolidating the iron/B12/malabsorption cluster.


---

## Original: topics/ferritin-iron-workup.md

```markdown
---
topic: Ferritin and Iron Workup
tags: [hematology, iron-deficiency, ferritin, transferrin-saturation, gi-bleeding, oral-iron]
priority: important
last_updated: 2026-04-30
confidence: high
abstract: >-
  Ferritin rebounded and hemoglobin is normal, so this is not current iron-deficiency anemia.
  Low iron/borderline TSAT plus positive stool blood still leaves occult GI loss unresolved;
  repeat trends and source clarification should come before routine iron loading.
---

# Ferritin Decline Workup & Iron Strategy

*Hematology · Iron Deficiency · GI · Workup Algorithm*

## The Clinical Picture

The old ferritin story was a decline from ~94 to 35 ug/L. The April 2026 update changed that: ferritin rebounded to 54.01 ug/L and hemoglobin is normal at 14.4, while serum iron is low, derived TSAT is borderline-low at ~19%, CRP remains normal, and stool occult blood is now POSITIVE. In other words, this is **not iron-deficiency anemia right now**, but it remains an **occult-blood / iron-monitoring problem** where the next trend matters more than any single serum-iron value.

## Workup Algorithm — Distinguishing Causes

### Step 1: Confirm True Iron Deficiency

- Ferritin is no longer frankly low by itself (54.01 ug/L), and CRP is not high, so the April snapshot is not classic absolute iron deficiency
- Low serum iron + derived TSAT around 19% are weaker, more variable signals; they support repeat monitoring rather than a diagnosis by themselves
- Positive stool blood keeps occult GI blood loss on the table even though hemoglobin recovered
- Add / recheck serum iron, TIBC, and TSAT only with the next planned blood draw or if symptoms/labs worsen; a stand-alone repeat just to chase serum iron is low value
- TSAT <20% remains a useful warning flag, especially if ferritin falls again or inflammation rises
- Non-anemic iron deficiency alone is a weaker indication for invasive investigation, but positive stool blood is an additional indication; see `occult-stool-blood-workup.md`

### Step 2: Identify the Cause

In adult males, the most common cause of iron deficiency is **occult GI blood loss**. However, other causes must be considered:

| Cause | Probability | Test |
| --- | --- | --- |
| Occult GI blood loss (lower GI / diverticular or other source) | High | Current FOB is already positive; use follow-up CBC/ferritin trends and GI review rather than pretending the stool branch is still hypothetical |
| Upper GI blood loss (gastritis, ulcer from alcohol) | Moderate | Still plausible, especially if stool blood persists or iron markers worsen without clear lower-GI evidence |
| Dietary deficiency | Low-moderate | Diet review — unlikely to cause this degree of decline in 6mo |
| Malabsorption (celiac/autoimmune gastritis) | Low-moderate | Use the trigger-based screen in [Celiac + Autoimmune Gastritis + Malabsorption Screen](#sec-malabsorption-screen); do not shotgun this branch unless iron/B12/symptom trends justify it |
| Chronic inflammation sequestering iron | Moderate | Check CRP/ESR — inflammation raises ferritin (as acute phase reactant) |

## Iron Supplementation — Boundary Only

This page owns diagnosis/source/escalation. The detailed product, dose, timing, duration, and tolerability protocol lives in [Oral Iron Repletion Strategy](#sec-oral-iron).

For this diagnostic page, keep only the boundary:

- Do not delay stool-blood/GI-source workup just because oral iron is possible.
- Oral iron can be a reasonable bridge if ferritin/TSAT drift, symptoms suggest depletion, or a clinician wants cautious repletion while the source is clarified.
- Use conservative alternate-day low-dose iron if used; reassess ferritin/TSAT/Hb after ~6-8 weeks.
- Visible bleeding, melena, rapidly worsening anemia, or persistent stool blood with worsening iron markers should escalate the source investigation ahead of supplement optimization.

### Evidence note

Alternate-day oral iron has supportive but mixed evidence. Hepcidin physiology supports avoiding high-dose consecutive-day exposure, while RCTs/meta-analyses generally show similar hemoglobin/ferritin outcomes between daily and alternate-day dosing, with alternate-day often better tolerated. That evidence belongs to the dosing page; here it simply means oral iron is optional, conservative, and not a substitute for following the stool-blood branch.

## When to Escalate to IV Iron

- If oral iron is not tolerated (GI side effects)
- If ferritin does not rise by >10 ug/L after 8 weeks of alternate-day dosing
- If hemoglobin starts to decline despite supplementation

## Key Takeaways

1. Ferritin is no longer the lone headline — the current state is normal hemoglobin + ferritin rebound + borderline TSAT + positive stool blood
2. The April snapshot does not prove active absolute iron deficiency, but it does justify planned repeat monitoring because stool blood is positive
3. Oral iron can be reasonable in parallel, but only as a bridge; it must not obscure whether bleeding persists. The practical dosing/tolerance plan now lives in [Oral Iron Repletion Strategy](#sec-oral-iron).
4. Recheck the full iron panel (ferritin, serum iron, TIBC/TSAT, CRP) with the next planned blood draw, not as a panic repeat solely for serum iron
5. If stool blood clears and Hb/ferritin/TSAT stabilize, monitoring is reasonable; if stool blood persists or ferritin falls toward <45-50 with TSAT <20%, GI referral logic strengthens
6. If oral iron is started, reassess after ~6-8 weeks; poor response points toward absorption/tolerance problems or continuing loss

## Research Trace

- 2026-04-25 clinical-decision synthesis: checked live cloud doc, current ferritin topic, queue, AGA GI evaluation guidance, BSG adult IDA guideline, non-anaemic iron deficiency review, serum-iron variability paper, and alternate-day oral-iron evidence.
- Durable delta: sharpened April interpretation from "active iron-loss" to "not IDA now, but occult-blood + borderline TSAT require trend-based follow-up" and downgraded alternate-day iron wording from superior/confirmed to supportive-but-mixed.
- Evidence anchors: AGA IDA guideline PMID: 32810434; BSG IDA guideline PMID: 34497146; non-anaemic iron deficiency review PMID: 34908363; serum iron variability PMID: 12090432; alternate-day RCT PMID: 36725875; daily-vs-alternate systematic review PMID: 37979057.

```


---

## Original: topics/oral-iron-repletion.md

```markdown
---
topic: Oral Iron Repletion Strategy
tags: [iron, ferritin, supplementation, vegetarian-diet, gi-bleeding, hepcidin, oral-iron]
priority: monitor
last_updated: 2026-04-27
confidence: medium-high
abstract: >-
  Oral iron is a repletion tool, not a diagnostic shortcut. With normal hemoglobin, ferritin rebound, borderline-low iron/TSAT,
  and positive stool blood, the safest plan is conservative alternate-day iron only if trends or symptoms justify it, while the
  stool-blood branch remains visible. Success means ferritin/TSAT response without masking ongoing blood loss.
related_topics: [ferritin-iron-workup.md, occult-stool-blood-workup.md, planned-blood-tests.md, recommended-supplement-adjustments.md]
open_questions: [Should oral iron be started now, or only if ferritin/TSAT drift again after stool-blood follow-up? Which product is best tolerated locally?]
---

# Oral Iron Repletion Strategy

## SearchPlan

- **Question type:** therapy / intervention.
- **Question:** If iron repletion is used in this profile, what regimen is sustainable, how should it be timed, and what lab response counts as success?
- **Dag-specific context:** male 51, mostly vegetarian diet, diverticular bleed history, current positive stool occult blood/RBC, ferritin 54.01 ug/L after prior nadir 35.28, hemoglobin normal 14.4, serum iron low and derived TSAT around 19%, bloating/SIBO-MMC suspicion.
- **Concepts searched:** oral iron dosing frequency, hepcidin, alternate-day vs daily RCTs/meta-analyses, AGA iron deficiency update, tolerability and absorption tactics.
- **Stop condition:** concise use/skip rules and a practical regimen that does not obscure GI-source monitoring.

## Current Position

This is **not iron-deficiency anemia right now**. Hemoglobin is normal and ferritin rebounded. But oral iron remains a plausible tool if the next trend shows renewed depletion or if the goal is cautious repletion while the stool-blood question is being followed.

The key distinction:

- **Diagnostic problem:** why stool blood is positive and whether iron markers drift down again.
- **Repletion problem:** how to restore/maintain iron stores if deficiency is confirmed or trending.

Do not let iron supplementation make the diagnostic branch disappear. A ferritin bump from tablets does not prove bleeding stopped.

## When to Start vs Wait

| Situation | Iron strategy |
|---|---|
| Ferritin stable/improving, Hb normal, stool blood clears | Wait / food-first is reasonable |
| Ferritin falls toward <45-50 ug/L, TSAT stays <20%, Hb still normal | Conservative oral iron is reasonable while repeating stool/iron trend |
| Hb starts falling, ferritin drops, stool blood persists | Oral iron may be a bridge, but GI-source escalation matters more |
| Significant visible bleeding, melena, rapid weakness, Hb drop | Do not manage with supplements; urgent medical/GI evaluation |
| Oral iron worsens bloating/constipation significantly | Stop or reduce; repletion strategy must not break the gut experiment |

## Preferred Regimen If Used

| Variable | Practical choice |
|---|---|
| Form | Ferrous bisglycinate if available and tolerated; otherwise ferrous sulfate/fumarate/gluconate are acceptable but often harsher |
| Dose | Start low: **25-36 mg elemental iron every other day**; only consider 45-65 mg if response is poor and tolerated |
| Timing | Morning, empty stomach if tolerated; otherwise with a small non-calcium snack |
| Absorption support | 250-500 mg vitamin C or fruit; optional, not magic |
| Avoid around dose | Coffee/tea, calcium, magnesium, zinc, high-fiber supplements, antacids/PPIs if avoidable; separate by ~2 hours |
| Duration | Reassess after 6-8 weeks before committing to long-term use |
| Stop/adjust | constipation, dark stool confusion, bloating flare, abdominal pain, nausea, or no lab response |

For this profile, **alternate-day low-dose iron is the cleaner default**. The evidence does not prove it is always superior for hemoglobin/ferritin outcomes, but it fits the hepcidin biology and is often better tolerated. Tolerability matters here because constipation/bloating can confound gut tracking.

## What Counts as Success

At 6-8 weeks after starting:

| Marker pattern | Interpretation |
|---|---|
| Ferritin rises by ~10-30 ug/L, TSAT improves, Hb stable | Good repletion response |
| Ferritin rises but stool blood persists | Tablets are repleting stores, but bleeding-source branch remains active |
| Ferritin/TSAT do not improve | Ongoing loss, poor adherence/timing, malabsorption, wrong dose/form, or inflammation/iron sequestration |
| Hb falls despite iron | Escalate — supplementation is not keeping up with loss or another process is present |
| GI symptoms worsen | Regimen may be net harmful; reduce dose/form/frequency or stop |

Do not interpret black/dark stool on oral iron as proof of GI bleeding. Conversely, do not dismiss visible blood or positive FOB as “just the iron” without clinician/lab context.

## Food-First Support

Because the diet is mostly vegetarian, support the regimen with non-heme iron tactics:

- Pair legumes, tofu/tempeh, lentils, beans, pumpkin seeds, spinach/greens, and fortified foods with vitamin-C foods.
- Keep tea/coffee away from high-iron meals and iron tablets.
- Do not combine iron tablets with calcium/magnesium/zinc supplements.
- If using psyllium, separate it from iron by several hours.

## IV Iron Boundary

IV iron is not a default here. It becomes a clinician discussion if:

- oral iron is not tolerated despite low-dose alternate-day strategy
- ferritin/TSAT fail to respond after 6-8 weeks with good adherence and timing
- Hb declines or symptomatic anemia develops
- malabsorption or ongoing loss makes oral repletion unrealistic

## Key Takeaways for This Profile

1. Oral iron can be useful, but the current April snapshot does not mandate immediate iron loading.
2. If used, start low and alternate-day to protect tolerability and reduce gut-confounding.
3. Success is a measured ferritin/TSAT response after 6-8 weeks, not “feeling a bit better” alone.
4. Persistent stool blood or falling Hb/ferritin overrides supplement optimization and points back to GI-source logic.
5. Keep iron separate from coffee/tea/calcium/magnesium/zinc/psyllium so a poor response is not self-inflicted.

## Research Trace

- **Research date:** 2026-04-27.
- **Research mode:** therapy / intervention synthesis.
- **Sources searched:** existing ferritin/occult-blood/supplement KB topics, live cloud doc, PubMed, AGA clinical practice update, alternate-day oral iron RCT/meta-analysis literature.
- **Evidence anchors:** AGA Clinical Practice Update on IDA (PMID: 38864796); hepcidin/daily dosing physiology (PMID: 26289639); alternate-day absorption study (PMID: 31413088); alternate-day vs daily RCT (PMID: 36725875); systematic review (PMID: 37979057).
- **Unresolved gaps:** whether stool blood clears; whether ferritin/TSAT drift after the clean month; which local product is best tolerated.

```


---

## Original: topics/malabsorption-celiac-autoimmune-gastritis.md

```markdown
---
topic: Celiac + Autoimmune Gastritis + Malabsorption Screen
tags: [celiac, autoimmune-gastritis, malabsorption, iron, b12, bloating, iga]
priority: important
last_updated: 2026-05-03
confidence: medium-high
related_topics: [ferritin-iron-workup.md, b12-functional-deficiency.md, elevated-iga-workup.md, sibo-mmc.md, post-30-day-noninvasive-exam-plan.md]
open_questions:
  - Can Biomed arrange off-menu/send-out tTG-IgA or is another Phnom Penh hospital/lab needed?
  - Do end-of-experiment iron/B12/stool/symptom trends justify screening now, or can this branch be dropped?
abstract: >-
  The malabsorption branch should stay small and trigger-based. Celiac testing is reasonable if iron/TSAT
  drift, chronic non-bloody diarrhea, weight loss, or persistent unexplained bloating make it actionable,
  but the first-line test is tTG-IgA while eating gluten; total IgA is already not deficient, and Biomed's
  public tariff does not list tTG, DGP, EMA, or HLA-DQ2/DQ8. Autoimmune gastritis/pernicious physiology
  is not a default add-on now because gastrin is normal and there is no macrocytic anemia, but it becomes
  relevant if B12/iron status worsens or fails to respond to oral replacement.
---

# Celiac + Autoimmune Gastritis + Malabsorption Screen

## Summary

Classification: **INTEGRATE**. The active queue item resolves to a compact testing boundary, not a broad autoimmune or malabsorption panel.

The useful rule is:

1. **Celiac branch:** if pursued, start with **tTG-IgA while eating gluten**. Total IgA is already elevated rather than deficient, so IgA deficiency is not the confounder here.
2. **Autoimmune-gastritis branch:** do **not** shotgun intrinsic-factor/parietal-cell/pepsinogen testing now. Trigger it only if B12 or iron behavior points to gastric malabsorption, or if gastroscopy happens anyway.
3. **Bloating branch:** persistent bloating alone is not enough for broad malabsorption testing. Combine it with objective signals: iron/TSAT/Hb drift, chronic non-bloody diarrhea/steatorrhea, weight loss, refractory B12 pattern, or clinician concern.

## Current signal

The cloud document already contains the anchors that matter for this branch: an old negative tTG-IgA from 2015, current elevated total IgA, low-normal/recurrent B12, normal folate history, upper-normal homocysteine, normal gastrin in April 2026, no macrocytic anemia, ferritin/TSAT monitoring rather than frank iron-deficiency anemia, persistent bloating, normalized calprotectin, and a live stool-blood branch. That mix justifies a **screen if the end-of-experiment pattern still points there**, but not a large panel by default.

## Decision pathway

| Trigger | Minimal action | Drop / escalate rule |
|---|---|---|
| Persistent unexplained iron problem: ferritin falling toward <45-50, TSAT <20, MCV/RDW drift, or Hb decline after the clean month | Ask for **tTG-IgA** while eating gluten; total IgA does not need repeating solely to rule out IgA deficiency | If tTG-IgA negative on a gluten-containing diet and no stronger symptoms, celiac becomes low priority; if positive/high, GI confirmation pathway opens. |
| Chronic non-bloody diarrhea, steatorrhea, weight loss, refractory aphthous ulcers, dermatitis-herpetiformis-like rash, or clear malabsorptive pattern | tTG-IgA becomes higher priority even if iron is stable | Positive/high tTG-IgA or red flags should go through GI, not diet self-diagnosis. |
| Already gluten-restricted before testing | Do not trust negative serology | Either defer testing until adequate gluten exposure or ask GI about formal gluten challenge/HLA-DQ2/DQ8. |
| tTG-IgA unavailable locally | Ask exact off-menu/send-out wording; do not substitute HLA-B27 or generic IgA/IgG | DGP-IgG/EMA/HLA-DQ2/DQ8 are second-line clarification tools, not the first local screen. |
| B12 stays low/functional symptoms persist despite adequate oral B12, or homocysteine/MMA pattern supports deficiency | Consider autoimmune-gastritis workup: intrinsic-factor antibody first for specificity, parietal-cell antibody for sensitivity if available; repeat fasting gastrin/pepsinogen only if accessible and interpretable | Normal gastrin and no macrocytosis/anemia make advanced pernicious physiology less likely now; worsening pattern or failed oral response changes that. |
| Gastroscopy becomes indicated for persistent stool blood/iron or upper-GI symptoms | If atrophic gastritis is suspected, ask for gastric body + antrum/incisura biopsies in separately labelled jars, plus H. pylori assessment | Histology, not serum antibodies alone, confirms atrophic/autoimmune gastritis. |

## Local test availability

Biomed public tariff check on 2026-05-03:

| Test / branch | Public Biomed status | Use here |
|---|---|---|
| tTG-IgA / anti-TG2 IgA | **Not listed** under transglutaminase/tTG/celiac/coeliac | Ask counter or another hospital/lab by exact name. |
| DGP IgA/IgG, EMA, HLA-DQ2/DQ8 | **Not listed** | Second-line only; HLA-B27 is not a celiac HLA test. |
| Total IgA | Listed, $10 | Already high, so not needed just to validate tTG-IgA. |
| B12, folate, homocysteine | Listed: B12 $17.50, folate $16.25, homocysteine $25 | Functional B12 follow-up if symptoms or supplement trial make it useful. |
| MMA / active B12 | Not listed | Do not assume local access. |
| Intrinsic-factor Ab, parietal-cell Ab, pepsinogen I/II | Not listed | Ask as off-menu/send-out only if trigger threshold is met. |
| Gastrin | Listed, $19.50; already normal in April 2026 | Repeat only if gastric-malabsorption suspicion changes. |
| H. pylori stool antigen | Listed, $15; prior stool antigen was negative in Dec 2025 | Repeat only with upper-GI/iron-loss trigger or clinician request. |

## Practical order rule

For the post-experiment visit, do **not** automatically add this branch to the core repeat panel.

Add **one** celiac action if triggered: `tTG-IgA while eating gluten` if Biomed can send it out, or ask another Phnom Penh hospital/lab for that exact test. Add total IgA only if the lab requires same-day pairing; clinically, IgA deficiency is already ruled out by the high total IgA.

Add autoimmune-gastritis testing only if the B12/iron pattern worsens, oral B12 response is poor, gastrin rises, there are upper-GI features, or gastroscopy is being done anyway. In that case, antibodies are supportive; biopsy distribution and H. pylori assessment matter more for diagnosis.

## Evidence / context

Adult celiac guidelines keep the initial screen narrow: validated IgA anti-TG2/tTG-IgA with total IgA, performed while the patient is eating gluten. The 2025 ESsCD guideline lists chronic iron deficiency/anemia, postprandial bloating, dyspepsia, recurrent abdominal pain, IBS-like presentations, autoimmune atrophic gastritis, and several autoimmune/dermatologic/oral conditions as testing indications, but it also discourages mass screening and routine multi-test serology. HLA-DQ2/DQ8 is useful mainly when diagnosis is uncertain because a negative result makes celiac very unlikely; it is not a first-line screen.

Autoimmune gastritis is different: AGA guidance treats atrophic gastritis as a histologic diagnosis. Parietal-cell antibodies are more sensitive but less specific; intrinsic-factor antibodies are more specific but insensitive and often appear later. Iron deficiency can precede B12 deficiency in autoimmune gastritis, but in this profile a normal gastrin and absence of macrocytic anemia argue against advanced pernicious physiology right now.

## References

- ESsCD 2025 adult celiac diagnostic guideline: PMID: 40999951.
- ACG 2023 celiac guideline update: PMID: 36602836.
- AGA atrophic gastritis clinical practice update: PMID: 34454714.
- Autoimmune gastritis clinical management review: PMID: 34484423.
- Corpus-restricted atrophic gastritis biomarker study: PMID: 36428844.

```


---

## Original: topics/b12-functional-deficiency.md

```markdown
---
topic: B12 / Functional Deficiency Follow-up
tags: [b12, homocysteine, vegetarian-diet, brain-fog, neurology, malabsorption]
priority: monitor
last_updated: 2026-05-04
confidence: medium-high
abstract: >-
  Serum B12 is low-normal rather than frankly deficient, but the pattern is not ignorable: vegetarian diet,
  recurrent B12 values near the lower range, upper-normal homocysteine, brain-fog context, and possible
  gut/SIBO-malabsorption overlap. NICE 2024 explicitly warns that B12 deficiency can occur without anemia
  or macrocytosis. The practical next step is not a large panel; it is either low-risk oral B12 replacement
  with symptom/lab follow-up, or targeted functional testing with homocysteine plus folate, and MMA only if
  accessible or if symptoms persist despite apparently adequate B12.
---

# B12 / Functional Deficiency Follow-up

## Current Dag-specific signal

| Marker | Pattern | Interpretation |
|---|---:|---|
| Vitamin B12 | 231 pmol/L on 2026-04-19; prior values 396, 279, 193, 228, 291 pmol/L | Low-normal and recurrently near the lower range, not a one-off collapse. |
| Homocysteine | 11.9 μmol/L in 2025; prior 10.6-11.9 | Upper-normal, compatible with suboptimal B12/folate/B6 status but not diagnostic alone. |
| Folate | 26.1 nmol/L in 2025; historically adequate | Folate deficiency is unlikely to be the main explanation, but rechecking helps interpret homocysteine. |
| CBC | No macrocytic anemia signal in current summary | Does **not** rule out B12 deficiency; NICE 2024 says absence of anemia or macrocytosis must not exclude B12 deficiency. |
| Diet / gut context | Vegetarian-leaning diet, bloating/SIBO-MMC question, prior alcohol pattern | Raises pre-test probability for dietary insufficiency or absorption overlap. |

## Evidence anchor

NICE NG239 (2024), Vitamin B12 deficiency in over 16s: diagnosis and management (https://www.nice.org.uk/guidance/ng239), is the best current practical framework:

- test when at least one symptom/sign plus at least one risk factor is present;
- cognitive difficulty, difficulty concentrating, short-term memory loss, brain fog, paraesthesia, balance issues, glossitis, fatigue, and abnormal blood count findings are recognized signs;
- low-animal-source diets are a risk factor;
- do **not** rule out B12 deficiency just because hemoglobin or MCV is normal;
- use total B12 or active B12 as the front-line test;
- if total B12 is indeterminate and symptoms fit, consider serum methylmalonic acid (MMA);
- if autoimmune gastritis is suspected, consider anti-intrinsic-factor antibody testing, then anti-parietal-cell/gastrin/gastroscopy logic if suspicion remains.

## Biomed availability checked

Biomed Phnom Penh tariff entries used here:

| Test | Biomed listing | Turnaround | Price | Use here |
|---|---|---:|---:|---|
| Vitamin B12 | B12 / Vitamin B12 / Cyanocobalamin | 1 day | $17.50 | Already measured in April; repeat only if tracking response. |
| Folate | Folate (Folic Acid) | 1 day | $16.25 | Useful with homocysteine interpretation. |
| Homocysteine | Homocysteine total | 3-5 days | $25.00 | Best local functional proxy if MMA is not available. |
| MMA | Not found on Biomed tariff search | — | — | Do not assume local availability; ask Biomed directly or use Bangkok/overseas only if clinically worth it. |

## Practical decision tree

### If no clear neurologic symptoms

Do not over-medicalize this. Use low-risk **maintenance** support:

- oral B12 1000 mcg cyanocobalamin or methylcobalamin 2-3 times/week, or 250-500 mcg/day;
- no need for injections;
- recheck B12 + homocysteine + folate in 8-12 weeks if this becomes an active experiment.

### If brain fog, fatigue, paraesthesia, balance issues, glossitis, or memory symptoms are present

Treat the B12 status as actionable even if CBC is normal. This is a short **repletion trial**, not the maintenance default:

1. Start oral B12 1000 mcg/day for 8-12 weeks, then step down to a maintenance schedule if symptoms/labs improve.
2. Add homocysteine + folate at the next blood draw if not already ordered.
3. If symptoms persist or worsen despite oral B12, ask whether MMA testing is available and consider clinician review for malabsorption or neurologic causes.
4. If there are objective neurologic signs (new numbness, gait/balance problems, visual symptoms), do not wait for a supplement experiment; clinician review and possible IM B12 are more appropriate.

### If B12 rises but homocysteine stays high

Think beyond B12:

- folate status;
- B6 status;
- thyroid status;
- renal function;
- alcohol relapse;
- inflammatory/gut context;
- genetics/MTHFR only if a clinician has a reason — not a first-line rabbit hole.

### If B12 does not rise on oral dosing

This argues for one of:

- inconsistent dosing;
- poor product/adherence;
- malabsorption / celiac physiology;
- autoimmune gastritis/pernicious-anemia physiology;
- ongoing SIBO/intestinal malabsorption.

Use the trigger-based [Celiac + Autoimmune Gastritis + Malabsorption Screen](#sec-malabsorption-screen) rather than adding a broad antibody panel by default. At that point, repeat oral advice is less useful; investigate cause or switch route under clinician guidance.

## Supplement interaction logic

This is one of the few supplement additions that is genuinely low-risk and high-upside. It should not crowd out the main cardiovascular/gut priorities, but it is a reasonable baseline support in a vegetarian diet.

Preferred simple rule:

- B12 can be taken with or without food;
- separate it from nothing important;
- do not combine the interpretation with a new multivitamin containing high folate/B6 unless the goal is specifically broad B-vitamin repletion;
- avoid megadose B6 as a casual add-on because chronic high B6 can cause neuropathy and muddy symptom interpretation.

## What would change management

| Result / event | Meaning | Action |
|---|---|---|
| Homocysteine normalizes after B12 | Functional B-vitamin signal likely improved | Continue maintenance dosing. |
| B12 remains low-normal and homocysteine remains high | B12 dose/product/adherence or absorption issue | Increase consistency, ask about MMA/active B12, consider malabsorption workup. |
| Neurologic symptoms appear | Higher stakes than routine supplementation | Clinician review; consider IM route. |
| CBC develops macrocytosis/anemia | Deficiency or mixed anemia becomes more likely | Treat and investigate cause rather than just supplement casually. |
| B12 high after supplementation but symptoms unchanged | B12 less likely primary driver | Stop escalating B12; look at sleep, BP, glucose/insulin, thyroid, inflammation, alcohol, and SIBO. |

## Current conclusion

The April B12 value is not an emergency, but it is below where it should be for a stable vegetarian-leaning 51-year-old with brain-fog/gut context. The cleanest next move is oral B12 repletion plus homocysteine/folate follow-up, not broad exotic testing. MMA would be useful only if locally available or if symptoms persist despite an adequate oral trial.

```